Abstract
Recent advances in genetics, molecular pathology and oncology have led to discovery of specific genetic changes and distinctive metabolic pathways that contribute to tumorigenesis as well as determine the biological behavior and imaging findings of a multitude of renal cell carcinomas. Multiphase CT and multiparametric MRI play major roles in the detection, localization, characterization, staging, surveillance, and follow-up of kidney cancers. While some imaging features are characteristic enough to suggest a tissue diagnosis, histopathology is required for definitive diagnosis, treatment, and prognostication.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
